InvestorsHub Logo
Followers 72
Posts 4262
Boards Moderated 2
Alias Born 08/21/2015

Re: bababeely post# 1106

Monday, 11/02/2020 8:03:11 AM

Monday, November 02, 2020 8:03:11 AM

Post# of 9432
What's great is that MindMed didn't seem to have to pay for this study either. The cash they have will pave the way for Phase 2 studies:

https://www.nature.com/articles/s41386-020-00883-6#Sec20

---

This work was supported by the Swiss National Science Foundation (grant no. 32003B_185111 to MEL). MEL is a consultant for Mind Medicine, Inc. The other authors declare no competing interests. Knowhow and data associated with this work and owned by the University Hospital Basel were licensed by Mind Medicine, Inc., after study completion. Mind Medicine, Inc. had no role in financing, planning, or conducting the present study or the present publication. Open Access funding provided by Universität Basel (Universitätsbibliothek Basel).

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNMD News